Debt-to-equity of NEVRO CORP from 30 Jun 2015 to 31 Dec 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NEVRO CORP quarterly Debt-to-equity in % history and change rate from 30 Jun 2015 to 31 Dec 2024.
  • NEVRO CORP Debt-to-equity for the quarter ending 31 Dec 2024 was 122%, a 23% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

NEVRO CORP Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2024 122% +23% +23% 31 Dec 2024
Q3 2024 117% +26% +28% 30 Sep 2024
Q2 2024 112% +23% +26% 30 Jun 2024
Q1 2024 105% +9.6% +10% 31 Mar 2024
Q4 2023 99% -3.1% -3% 31 Dec 2023
Q3 2023 91% -12% -12% 30 Sep 2023
Q2 2023 89% -14% -13% 30 Jun 2023
Q1 2023 95% +8% +9.2% 31 Mar 2023
Q4 2022 102% +14% +16% 31 Dec 2022
Q3 2022 104% +12% +13% 30 Sep 2022
Q2 2022 103% +5.4% +5.5% 30 Jun 2022
Q1 2022 87% -18% -17% 31 Mar 2022
Q4 2021 88% -17% -16% 31 Dec 2021
Q3 2021 92% -16% -15% 30 Sep 2021
Q2 2021 97% -15% -13% 30 Jun 2021
Q1 2021 105% -14% -12% 31 Mar 2021
Q4 2020 105% -15% -12% 31 Dec 2020
Q3 2020 108% -3.9% -3.5% 30 Sep 2020
Q2 2020 112% +11% +11% 30 Jun 2020
Q1 2020 120% +28% +30% 31 Mar 2020
Q4 2019 120% +35% +41% 31 Dec 2019
Q3 2019 111% +28% +34% 30 Sep 2019
Q2 2019 101% +19% +23% 30 Jun 2019
Q1 2019 92% +12% +15% 31 Mar 2019
Q4 2018 85% +7.8% +10% 31 Dec 2018
Q3 2018 83% +8.5% +11% 30 Sep 2018
Q2 2018 82% +9.7% +13% 30 Jun 2018
Q1 2018 80% +9.4% +13% 31 Mar 2018
Q4 2017 77% +19% +33% 31 Dec 2017
Q3 2017 75% +29% +63% 30 Sep 2017
Q2 2017 72% +40% +122% 30 Jun 2017
Q1 2017 70% +52% +277% 31 Mar 2017
Q4 2016 58% +39% +210% 31 Dec 2016
Q3 2016 46% +29% +170% 30 Sep 2016
Q2 2016 33% +10% +47% 30 Jun 2016
Q1 2016 19% 31 Mar 2016
Q4 2015 19% 31 Dec 2015
Q3 2015 17% 30 Sep 2015
Q2 2015 22% 30 Jun 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.